Table 1.
Baseline Characteristics, Overall and by Incident VTE, in Patients Hospitalized for COVID‐19
| Characteristic | Overall (N=1960) | Incident VTE during hospitalization (N=163) | No VTE during hospitalization (N=1797) |
|---|---|---|---|
| Age, y | 58 (17) | 57 (15) | 58 (17) |
| Men | 1114 (57) | 122 (75) | 992 (55) |
| Body mass index, kg/m2 | 32 (9) | 31 (10) | 32 (9) |
| Black race | 385 (20) | 48 (30) | 337 (20) |
| Diabetes | 571 (29) | 51 (31) | 520 (29) |
| Hypertension | 954 (49) | 91 (56) | 863 (48) |
| Congestive heart failure | 179 (9) | 10 (6) | 169 (9) |
| Atrial fibrillation or flutter | 172 (9) | 7 (4) | 165 (9) |
| Stroke | 121 (6) | 9 (5) | 112 (9) |
| Chronic obstructive pulmonary disease | 170 (9) | 15 (9) | 155 (9) |
| Malignancy | 82 (4) | 14 (9) | 68 (4) |
| Before admission anticoagulation therapy | 177 (9) | 9 (6) | 168 (9) |
| Creatinine, mg/dL* | 1.0 (0.8–1.4) | 1.0 (0.9–1.5) | 1.0 (0.8–1.3) |
| D‐dimer, mg/L† | 1.0 (0.6–2.6) | 2.1 (1.1–10.4) | 1.0 (0.5–2.2) |
| suPAR, ng/mL | 6.7 (4.5–10.1) | 9.7 (6.2–13.8) | 6.5 (4.4–9.7) |
Data are given as mean (SD), number (percentage), or median (interquartile range). suPAR indicates soluble urokinase plasminogen activator receptor; and VTE, venous thromboembolism.
Serum creatinine normal range: 0.65 to 1.00 mg/dL (University of Michigan and Rush University Medical Center), 0.57 to 1.02 mg/dL for women and 0.68 to 1.19 mg/dL for men (Copenhagen University Hospital Hvidovre), 0.50 to 0.90 ng/mL (University of Thessaly), and 0.50 to 0.9 mg/dL for women and 0.70 to 1.20 mg/dL for men (Attikon University Hospital in Athens, University Hospital of Düsseldorf, and Charité University Medicine).
D‐dimer normal range: 0.000 to 0.500 mg/L (University of Michigan, Copenhagen University Hospital Hvidovre, Attikon University Hospital in Athens, University Hospital of Düsseldorf, and Charité University Medicine), 0.000 to 0.600 mg/L (Rush University Medical Center), and 0.000 to 0.255 mg/L (University of Thessaly).